Roelien Postema

Roelien Postema currently serves as Principal Market Access at Putnam since November 2022. Prior experience includes the role of Global Health Economics and Market Access Director at Galapagos from January 2021 to March 2022. A significant tenure at Bristol-Myers Squibb from January 2013 to January 2021 featured responsibilities as Worldwide HEOR Oncology and Associate Director for various markets. Previous positions include Pricing, Reimbursement & Access Associate at Eli Lilly and Company, and Research Consultant HEOR at Pharmerit, where Roelien developed global cost-effectiveness models and conducted health economics research. Early career roles involved internships and student assistance at medical and academic institutions. Roelien holds a Post Graduate Diploma in Epidemiology from the London School of Hygiene and Tropical Medicine and a PharmD from the University of Groningen.